Skip to main content
BOIRON logo

BOIRON — Investor Relations & Filings

Ticker · BOI ISIN · FR0000061129 LEI · 9695000UMPNY21KKDO98 PA Manufacturing
Open in API
Filings indexed 556 across all filing types
Latest filing 2026-04-29 Proxy Solicitation & In…
Country FR France
Listing PA BOI

About BOIRON

https://www.boironfinance.fr/en

Boiron is an independent, family-owned pharmaceutical laboratory and a world leader in homeopathic medicines. Founded in 1932, the company specializes in the development and manufacturing of high-quality homeopathic products. Its portfolio includes a wide range of natural health remedies for various common health conditions and everyday ailments, with well-known product lines such as Arnicare® for pain relief. Boiron's products are used by millions of consumers globally and are also utilized by healthcare professionals.

Recent filings

Filing Released Lang Actions
Mise à disposition des documents préparatoires à l'Assemblée Générale Ordinaire annuelle du 21 mai 2026
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a formal convocation notice for the Annual General Meeting (Ordinaire) of Boiron on 21 May 2026, detailing agenda publication, access to preparatory documents, and voting instructions. It is not the actual AGM presentation or the full annual report, but rather the materials sent to shareholders to inform them of the meeting and request their votes. This matches the definition of Proxy Solicitation & Information Statement (PSI).
2026-04-29 French
Rapport financier annuel 2025
Annual Report (ESEF) Classification · 1% confidence FY 2025
2026-04-22 French
Mise à disposition du rapport financier annuel 2025
Report Publication Announcement Classification · 1% confidence The document is a brief notice entitled “Mise à disposition du Rapport Financier Annuel 2025” stating that the annual financial report for 2025 has been filed with the AMF and providing a link to consult it online. It does not contain the report itself but merely announces its availability. This fits the definition of a Report Publication Announcement (RPA).
2026-04-22 French
Déclaration des droits de vote au 31 mars 2026
Regulatory Filings Classification · 1% confidence The document is a French regulatory notice (under articles L.233-8 II of the French Commercial Code and AMF rule 223-16) publishing the total number of shares composing the capital and voting rights as of March 31, 2026. It is not an AGM presentation, financial report, dividend notice, capital increase, or insider transaction, but a periodic regulatory disclosure. This falls under the general Regulatory Filings category (RNS).
2026-04-09 French
CHIFFRE D'AFFAIRES ET RÉSULTATS 2025
Earnings Release Classification · 1% confidence The document is a press release dated 2 April 2026 summarizing key financial results for the full year ended 31 December 2025 (revenue, operating profit, net income, EBITDA, cash metrics), contains narrative commentary on performance drivers, proposes a dividend, and provides a next publication date. It is not the full annual report but the initial public announcement of annual results. This aligns with an Earnings Release. FY 2025
2026-04-02 French
Déclaration des droits de vote au 28 février 2026
Regulatory Filings Classification · 1% confidence The document is a regulatory disclosure from Boiron regarding the total number of shares and voting rights, as required by French commercial law (Article L. 233-8 II) and AMF regulations. This type of disclosure is a standard regulatory filing for publicly traded companies in France. Since it does not fit into specific categories like M&A, dividends, or director dealings, it falls under the general regulatory filing category.
2026-03-04 French

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.